Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

100196

	registered interest
	date	21/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether the signature authorising Individual Funding Requests made to NHS England for Gamma Knife treatment by University College Hospital London, Queen Square, is that of a senior clinician employed by University College Hospital London.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	211310
	answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>We are advised by NHS England that the clinician who authorises Individual Funding Requests for Gamma Knife treatment to be undertaken at the Queens Square Radiology Centre Ltd (QSRC) is a surgeon at the National Hospital for Neurosurgery and Neurology (NHNN), part of University College London Hospitals NHS Foundation Trust (UCLH).</p><p> </p><p> </p><p> </p><p>Gamma Knife treatment is not undertaken by UCLH but by the private company QSRC, which is based at NHNN but has no formal relationship with UCLH.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/10/2014 16:54:23 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt

48954

	registered interest
	date	29/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, pursuant to section 3 of the guidance issued by Monitor on the Commissioning of Radiosurgery Services on 4 April 2014, if NHS England will publish the details of all contracts it has signed with providers of radiosurgery services in England.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	197025
	answer	answer is ministerial correction date of answer 07/05/2014 answer text <p>Section 3 of Monitor's substantive guidance on <em>The National Health Service (Procurement, Patient Choice and Competition) (No.2) Regulations 2013</em> provides guidance to commissioners on publishing new contract opportunities for NHS health care services.</p><p> </p><p>On page 42 of the guidance, it states that &quot;a commissioner may decide to carry out a detailed review of the provision of particular services (for example, A&amp;E services) in its local area in order to understand how those services can be improved in the interests of patients. The review may involve extensive public consultation and engagement with existing and potential providers and other stakeholders. Reviewing available services and providers in this way is good commissioning practice and something that commissioners should consider doing as a matter of course.”</p><p> </p><p>NHS England is currently undertaking such a review of stereotactic radiosurgery services. This will inform procurement decisions for these services.</p><p> </p><p>University College London Hospitals is not contracted by NHS England, nor was it contracted by former primary care trusts, to provide Gamma Knife services. It is for this reason that NHS patients cannot normally be treated at this facility. Instead, NHS patients requiring Gamma Knife treatment should be treated by the Gamma Knife services commissioned by the NHS, that have been shown to meet NHS England service specifications. These can be accessed by patients in London without a waiting time, fully maintaining the continuity of their care and normally with the same consultant and clinical team.</p><p><strong> </strong></p><p>NHS England inherited the range of stereotactic surgery providers currently in place, of which University College Hospital London was not one. NHS England is currently undertaking a review of stereotactic radiosurgery provision and will consult widely with stakeholders and providers prior to making changes to service provision.</p><p> </p><p>Finally, NHS England will publish information relating to its contracted spend in due course, in line with Regulation 9 of <em>The National Health Service (Procurement, Patient Choice and Competition) (No.2) Regulations 2013</em>.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 197023 197024 question first answered 07/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt

48955

	registered interest
	date	29/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, pursuant to section 3 of the guidance issued by Monitor on the Commissioning of Radiosurgery Services on 4 April 2014, if he will require NHS England to publish the names of all referring consultants, patients groups, charities and any other service providers it consulted prior to making its decision not to allow patients to be treated with the Gamma Knife at University College London Hospital.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	197024
	answer	answer is ministerial correction date of answer 07/05/2014 answer text <p>Section 3 of Monitor's substantive guidance on <em>The National Health Service (Procurement, Patient Choice and Competition) (No.2) Regulations 2013</em> provides guidance to commissioners on publishing new contract opportunities for NHS health care services.</p><p> </p><p>On page 42 of the guidance, it states that &quot;a commissioner may decide to carry out a detailed review of the provision of particular services (for example, A&amp;E services) in its local area in order to understand how those services can be improved in the interests of patients. The review may involve extensive public consultation and engagement with existing and potential providers and other stakeholders. Reviewing available services and providers in this way is good commissioning practice and something that commissioners should consider doing as a matter of course.”</p><p> </p><p>NHS England is currently undertaking such a review of stereotactic radiosurgery services. This will inform procurement decisions for these services.</p><p> </p><p>University College London Hospitals is not contracted by NHS England, nor was it contracted by former primary care trusts, to provide Gamma Knife services. It is for this reason that NHS patients cannot normally be treated at this facility. Instead, NHS patients requiring Gamma Knife treatment should be treated by the Gamma Knife services commissioned by the NHS, that have been shown to meet NHS England service specifications. These can be accessed by patients in London without a waiting time, fully maintaining the continuity of their care and normally with the same consultant and clinical team.</p><p><strong> </strong></p><p>NHS England inherited the range of stereotactic surgery providers currently in place, of which University College Hospital London was not one. NHS England is currently undertaking a review of stereotactic radiosurgery provision and will consult widely with stakeholders and providers prior to making changes to service provision.</p><p> </p><p>Finally, NHS England will publish information relating to its contracted spend in due course, in line with Regulation 9 of <em>The National Health Service (Procurement, Patient Choice and Competition) (No.2) Regulations 2013</em>.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 197023 197025 question first answered 07/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt

48956

	registered interest
	date	29/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, pursuant to section 3 of the guidance issued by Monitor on the Commissioning of Radiosurgery Services on 4 April 2014, if he will require NHS England to publish the objective evidence on which it based its decision not to allow patients to be treated with the Gamma Knife at University College London Hospital.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	197023
	answer	answer is ministerial correction date of answer 07/05/2014 answer text <p>Section 3 of Monitor's substantive guidance on <em>The National Health Service (Procurement, Patient Choice and Competition) (No.2) Regulations 2013</em> provides guidance to commissioners on publishing new contract opportunities for NHS health care services.</p><p> </p><p>On page 42 of the guidance, it states that &quot;a commissioner may decide to carry out a detailed review of the provision of particular services (for example, A&amp;E services) in its local area in order to understand how those services can be improved in the interests of patients. The review may involve extensive public consultation and engagement with existing and potential providers and other stakeholders. Reviewing available services and providers in this way is good commissioning practice and something that commissioners should consider doing as a matter of course.”</p><p> </p><p>NHS England is currently undertaking such a review of stereotactic radiosurgery services. This will inform procurement decisions for these services.</p><p> </p><p>University College London Hospitals is not contracted by NHS England, nor was it contracted by former primary care trusts, to provide Gamma Knife services. It is for this reason that NHS patients cannot normally be treated at this facility. Instead, NHS patients requiring Gamma Knife treatment should be treated by the Gamma Knife services commissioned by the NHS, that have been shown to meet NHS England service specifications. These can be accessed by patients in London without a waiting time, fully maintaining the continuity of their care and normally with the same consultant and clinical team.</p><p><strong> </strong></p><p>NHS England inherited the range of stereotactic surgery providers currently in place, of which University College Hospital London was not one. NHS England is currently undertaking a review of stereotactic radiosurgery provision and will consult widely with stakeholders and providers prior to making changes to service provision.</p><p> </p><p>Finally, NHS England will publish information relating to its contracted spend in due course, in line with Regulation 9 of <em>The National Health Service (Procurement, Patient Choice and Competition) (No.2) Regulations 2013</em>.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 197024 197025 question first answered 07/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt

49236

	registered interest
	date	30/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what progress NHS England is making on improving access to stereotactic ablative radiotherapy for patients suffering with cancer of the prostate, liver, pancreas, spinal tumours and cancer of the head and neck.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	197267
	answer	answer is ministerial correction date of answer 08/05/2014 answer text <p>The business case for the gamma-knife centre at Oxford was originally agreed with the primary care trust (PCT) prior to April 2013, with an assumption that the PCT would stop sending patients to other centres elsewhere, and start sending them to the new centre once it was completed.</p><p> </p><p>As of April 2013, commissioning of these services transferred to the specialist commissioning team in NHS England.</p><p> </p><p>NHS England is currently undertaking a review of stereotactic radiosurgery (SRS) (e.g. Gamma Knife) and stereotactic ablative radiotherapy (SABR, e.g. Cyber-knife) for intracranial conditions to establish what the national demand is in line with its national clinical commissioning policies on SRS and SABR, and what the national capacity requirements are for this specialised treatment.</p><p> </p><p>Until the capacity requirements are clear, NHS England has said that it would be inappropriate to encourage new market entrants to provide this service as it cannot be clear what the potential consequential impacts on service quality, sustainability (financial and clinical) and potential unintended changes to patient pathways will be. Until the review is complete NHS England has said no substantive changes will be made to the current provision.</p><p> </p><p>As part of the transition of this service to NHS England, it developed, consulted upon and published a series of national clinical commissioning policies for intracranial SRS and SRT treatment.</p><p> </p><p>A report setting out the emerging findings of this review has been shared with clinical reference groups to seek their views and help NHS England develop a final draft. Once the views of stakeholders have been gathered, this will then go to Specialised Commissioning Oversight Group (SCOG) to agree a preferred option. Once the SCOG has a preferred option, NHS England will consult with patients and professionals and take account of those views when taking a final decision. If it is concluded there are to be significant changes in the provision of services, there will be a full public consultation before any changes are made.</p><p> </p><p>NHS England is expecting that the draft report will be ready for consideration at SCOG in June and then it would commence a public consultation on the draft report and preferred option during July to September. The report and recommendations will then be finalised after taking account of the views expressed during the consultation stage and a final decision taken by SCOG in September 2014.</p><p> </p><p>NHS England inherited the range of gamma knife providers currently in place, of which University College London Hospitals (UCLH) was not one. NHS England is currently undertaking a review of stereotactic radiosurgery provision and will consult widely with stakeholders and providers prior to making changes to service provision. There are two long established providers of gamma knife surgery commissioned by NHS England located in central London to whom patients from all six London specialist neurosurgical centres have been referred for gamma knife treatment for a number of years, including patients from UCLH.</p><p> </p><p>Finally, there was no contract in place with UCLH to provide gamma knife surgery for any PCT prior to 1 April 2013. Any activity that may have been undertaken there would have been done on an ad-hoc, non-contracted basis and NHS England does not hold this information.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 197268 197298 197299 question first answered 08/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt

49237

	registered interest
	date	30/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will take steps to encourage NHS England to respond to the Oxford Radiosurgery Centre's request that NHS patients in Oxfordshire and surrounding counties who require radiosurgery be treated there.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	197268
	answer	answer is ministerial correction date of answer 08/05/2014 answer text <p>The business case for the gamma-knife centre at Oxford was originally agreed with the primary care trust (PCT) prior to April 2013, with an assumption that the PCT would stop sending patients to other centres elsewhere, and start sending them to the new centre once it was completed.</p><p> </p><p>As of April 2013, commissioning of these services transferred to the specialist commissioning team in NHS England.</p><p> </p><p>NHS England is currently undertaking a review of stereotactic radiosurgery (SRS) (e.g. Gamma Knife) and stereotactic ablative radiotherapy (SABR, e.g. Cyber-knife) for intracranial conditions to establish what the national demand is in line with its national clinical commissioning policies on SRS and SABR, and what the national capacity requirements are for this specialised treatment.</p><p> </p><p>Until the capacity requirements are clear, NHS England has said that it would be inappropriate to encourage new market entrants to provide this service as it cannot be clear what the potential consequential impacts on service quality, sustainability (financial and clinical) and potential unintended changes to patient pathways will be. Until the review is complete NHS England has said no substantive changes will be made to the current provision.</p><p> </p><p>As part of the transition of this service to NHS England, it developed, consulted upon and published a series of national clinical commissioning policies for intracranial SRS and SRT treatment.</p><p> </p><p>A report setting out the emerging findings of this review has been shared with clinical reference groups to seek their views and help NHS England develop a final draft. Once the views of stakeholders have been gathered, this will then go to Specialised Commissioning Oversight Group (SCOG) to agree a preferred option. Once the SCOG has a preferred option, NHS England will consult with patients and professionals and take account of those views when taking a final decision. If it is concluded there are to be significant changes in the provision of services, there will be a full public consultation before any changes are made.</p><p> </p><p>NHS England is expecting that the draft report will be ready for consideration at SCOG in June and then it would commence a public consultation on the draft report and preferred option during July to September. The report and recommendations will then be finalised after taking account of the views expressed during the consultation stage and a final decision taken by SCOG in September 2014.</p><p> </p><p>NHS England inherited the range of gamma knife providers currently in place, of which University College London Hospitals (UCLH) was not one. NHS England is currently undertaking a review of stereotactic radiosurgery provision and will consult widely with stakeholders and providers prior to making changes to service provision. There are two long established providers of gamma knife surgery commissioned by NHS England located in central London to whom patients from all six London specialist neurosurgical centres have been referred for gamma knife treatment for a number of years, including patients from UCLH.</p><p> </p><p>Finally, there was no contract in place with UCLH to provide gamma knife surgery for any PCT prior to 1 April 2013. Any activity that may have been undertaken there would have been done on an ad-hoc, non-contracted basis and NHS England does not hold this information.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 197267 197298 197299 question first answered 08/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt

49238

	registered interest
	date	30/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many patients have been sent to hospitals in London for stereotactic radiosurgery treatment from (a) Oxfordshire, (b) Berkshire, (c) Buckinghamshire and (d) Wiltshire in each of the last three financial years.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	197271
	answer	answer is ministerial correction date of answer 08/05/2014 answer text <p>The requested information is not collected centrally.</p><p> </p><p>We understand Mr James Palmer, Clinical Director of Specialised Services at NHS England will be writing to my hon. Friend to offer a meeting in order that he can address concerns about the provision of stereotactic radiosurgery treatment.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 197263 question first answered 08/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt

49239

	registered interest
	date	30/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many patients have been sent to hospitals in Sheffield for stereotactic radiosurgery treatment from (a) Oxfordshire, (b) Berkshire, (c) Buckinghamshire and (d) Wiltshire in each of the last three financial years.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	197263
	answer	answer is ministerial correction date of answer 08/05/2014 answer text <p>The requested information is not collected centrally.</p><p> </p><p>We understand Mr James Palmer, Clinical Director of Specialised Services at NHS England will be writing to my hon. Friend to offer a meeting in order that he can address concerns about the provision of stereotactic radiosurgery treatment.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 197271 question first answered 08/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt

49240

	registered interest
	date	30/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, pursuant to the Answer of 24 March 2014, Official Report, column 132W, on radiotherapy and with reference to section three of the guidance issued by Monitor on the Commissioning of Radiosurgery Services on 4 April 2014, which primary care trusts in the south west of England commissioned treatment with the Gamma Knife at University College London Hospital for patients before 1 April 2013.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	197298
	answer	answer is ministerial correction date of answer 08/05/2014 answer text <p>The business case for the gamma-knife centre at Oxford was originally agreed with the primary care trust (PCT) prior to April 2013, with an assumption that the PCT would stop sending patients to other centres elsewhere, and start sending them to the new centre once it was completed.</p><p> </p><p>As of April 2013, commissioning of these services transferred to the specialist commissioning team in NHS England.</p><p> </p><p>NHS England is currently undertaking a review of stereotactic radiosurgery (SRS) (e.g. Gamma Knife) and stereotactic ablative radiotherapy (SABR, e.g. Cyber-knife) for intracranial conditions to establish what the national demand is in line with its national clinical commissioning policies on SRS and SABR, and what the national capacity requirements are for this specialised treatment.</p><p> </p><p>Until the capacity requirements are clear, NHS England has said that it would be inappropriate to encourage new market entrants to provide this service as it cannot be clear what the potential consequential impacts on service quality, sustainability (financial and clinical) and potential unintended changes to patient pathways will be. Until the review is complete NHS England has said no substantive changes will be made to the current provision.</p><p> </p><p>As part of the transition of this service to NHS England, it developed, consulted upon and published a series of national clinical commissioning policies for intracranial SRS and SRT treatment.</p><p> </p><p>A report setting out the emerging findings of this review has been shared with clinical reference groups to seek their views and help NHS England develop a final draft. Once the views of stakeholders have been gathered, this will then go to Specialised Commissioning Oversight Group (SCOG) to agree a preferred option. Once the SCOG has a preferred option, NHS England will consult with patients and professionals and take account of those views when taking a final decision. If it is concluded there are to be significant changes in the provision of services, there will be a full public consultation before any changes are made.</p><p> </p><p>NHS England is expecting that the draft report will be ready for consideration at SCOG in June and then it would commence a public consultation on the draft report and preferred option during July to September. The report and recommendations will then be finalised after taking account of the views expressed during the consultation stage and a final decision taken by SCOG in September 2014.</p><p> </p><p>NHS England inherited the range of gamma knife providers currently in place, of which University College London Hospitals (UCLH) was not one. NHS England is currently undertaking a review of stereotactic radiosurgery provision and will consult widely with stakeholders and providers prior to making changes to service provision. There are two long established providers of gamma knife surgery commissioned by NHS England located in central London to whom patients from all six London specialist neurosurgical centres have been referred for gamma knife treatment for a number of years, including patients from UCLH.</p><p> </p><p>Finally, there was no contract in place with UCLH to provide gamma knife surgery for any PCT prior to 1 April 2013. Any activity that may have been undertaken there would have been done on an ad-hoc, non-contracted basis and NHS England does not hold this information.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 197267 197268 197299 question first answered 08/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt

49241

	registered interest
	date	30/04/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, pursuant to the Answer of 24 March 2014, Official Report, column 132W, on radiotherapy and with reference to section three of the guidance issued by Monitor on the Commissioning of Radiosurgery Services on 4 April 2014, for what reasons NHS England is not funding patients to be treated with the Gamma Knife at University College London Hospital.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	197299
	answer	answer is ministerial correction date of answer 08/05/2014 answer text <p>The business case for the gamma-knife centre at Oxford was originally agreed with the primary care trust (PCT) prior to April 2013, with an assumption that the PCT would stop sending patients to other centres elsewhere, and start sending them to the new centre once it was completed.</p><p> </p><p>As of April 2013, commissioning of these services transferred to the specialist commissioning team in NHS England.</p><p> </p><p>NHS England is currently undertaking a review of stereotactic radiosurgery (SRS) (e.g. Gamma Knife) and stereotactic ablative radiotherapy (SABR, e.g. Cyber-knife) for intracranial conditions to establish what the national demand is in line with its national clinical commissioning policies on SRS and SABR, and what the national capacity requirements are for this specialised treatment.</p><p> </p><p>Until the capacity requirements are clear, NHS England has said that it would be inappropriate to encourage new market entrants to provide this service as it cannot be clear what the potential consequential impacts on service quality, sustainability (financial and clinical) and potential unintended changes to patient pathways will be. Until the review is complete NHS England has said no substantive changes will be made to the current provision.</p><p> </p><p>As part of the transition of this service to NHS England, it developed, consulted upon and published a series of national clinical commissioning policies for intracranial SRS and SRT treatment.</p><p> </p><p>A report setting out the emerging findings of this review has been shared with clinical reference groups to seek their views and help NHS England develop a final draft. Once the views of stakeholders have been gathered, this will then go to Specialised Commissioning Oversight Group (SCOG) to agree a preferred option. Once the SCOG has a preferred option, NHS England will consult with patients and professionals and take account of those views when taking a final decision. If it is concluded there are to be significant changes in the provision of services, there will be a full public consultation before any changes are made.</p><p> </p><p>NHS England is expecting that the draft report will be ready for consideration at SCOG in June and then it would commence a public consultation on the draft report and preferred option during July to September. The report and recommendations will then be finalised after taking account of the views expressed during the consultation stage and a final decision taken by SCOG in September 2014.</p><p> </p><p>NHS England inherited the range of gamma knife providers currently in place, of which University College London Hospitals (UCLH) was not one. NHS England is currently undertaking a review of stereotactic radiosurgery provision and will consult widely with stakeholders and providers prior to making changes to service provision. There are two long established providers of gamma knife surgery commissioned by NHS England located in central London to whom patients from all six London specialist neurosurgical centres have been referred for gamma knife treatment for a number of years, including patients from UCLH.</p><p> </p><p>Finally, there was no contract in place with UCLH to provide gamma knife surgery for any PCT prior to 1 April 2013. Any activity that may have been undertaken there would have been done on an ad-hoc, non-contracted basis and NHS England does not hold this information.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 197267 197268 197298 question first answered 08/05/2014 12:00:00 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt